MinorityHeartHealth.org
  • Home
  • About Us
  • Issues
    • Quality Measures
    • Veterans
    • 1,000,000 Hearts Initiative
    • Hospital Adherence
  • Facts and FIndings
    • The Data
    • The Evidence
    • Patient Access Study
    • NQF Quality Measure
  • Blog
  • Get Involved
    • Voices for Change
    • Join Us

Blog

NMQF Responds to Comments on Quality Measure for African Americans with Heart Failure

12/8/2015

0 Comments

 
Picture
The National Minority Quality Forum’s (NMQF) proposed trial eMeasure (#2764), “Fixed-dose Combination of Hydralazine and Isosorbide Dinitrate Therapy for Self-identified Black or African American Patients with Heart Failure and LVEF <40% on ACEI or ARB and Beta-blocker Therapy," received more than 40 comments during the National Quality Forum’s public and member comment period for their Cardiovascular Measures 2015 project that closed on November 23, 2015 (see NMQF's response here). The overwhelming majority of the comments voiced strong support for the September 9 decision of the NQF Cardiovascular Measures Standing Committee to approve NMQF’s trial measure, and to enable Measure #2764 to advance to the next stage of voting and to complete required testing of validity and reliability.


Read More
0 Comments

    Archives

    June 2017
    February 2017
    September 2016
    May 2016
    December 2015
    November 2015
    September 2015
    July 2015

    Categories

    All

Powered by Create your own unique website with customizable templates.
  • Home
  • About Us
  • Issues
    • Quality Measures
    • Veterans
    • 1,000,000 Hearts Initiative
    • Hospital Adherence
  • Facts and FIndings
    • The Data
    • The Evidence
    • Patient Access Study
    • NQF Quality Measure
  • Blog
  • Get Involved
    • Voices for Change
    • Join Us